Last week we talked about the evolution in the venture capital industry in this newsletter, today I’d like to take a closer look at another change we’re seeing in our space: The blurring of lines between wellness and medicine in women’s health.
When analyzing recent news in the women’s health space it appears that wellness-focused companies are increasingly adopting medical approaches, while medically-oriented firms are venturing into consumer wellness and over-the-counter offerings. It’s clear that this convergence is reshaping the industry, blurring the traditional boundaries between wellness and medicine.
In the wellness sector, we’re seeing a shift towards clinical evidence and regulatory approval. Companies once content with lifestyle products are now knee-deep in clinical trials and FDA clearance processes. It’s a sign of the industry’s maturation, moving beyond the initial femtech hype to deliver solutions that can work hand-in-hand with traditional healthcare systems.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
